Estimation of cardiovascular complications and death risk in subjects with metabolic syndrome
Journal Title: Archives of Medical Science - Year 2006, Vol 2, Issue 4
Abstract
Introduction: Coexistence of lipid and carbohydrate disorders with hypertension and obesity increases the risk of ischaemic heart disease and its complications. The recently observed lack of reduction in the incidence of cardiovascular system diseases is thought to be due to the growing epidemic of MS. The aim of the study was to estimate cardiovascular complications and death risk in subjects with MS. Material and methods: The prevention study included 581 subjects (213 males and 368 females): 250 born in 1949, 155 born in 1959 and 176 born in 1969. MS was diagnosed (on the basis of NCEP ATP III) in 104 individuals. Increased risk of cardiovascular complications was determined for pulse pressure (pp) >63 mmHg. Based on the SCORE index (algorithm), 10-year death risk due to cardiovascular complications was estimated taking into account sex, age, smoking, systolic blood pressure and total cholesterol concentration. A value ³5% was accepted as high risk of death within 10 years. Results: Increased risk of cardiovascular complications (pp >63 mmHg) was found in 21 subjects (20.2%) with MS and 34 (7.1%) without MS (p
Authors and Affiliations
Jan Kowalski, Marcin Barylski, Małgorzata Godala, Robert Irzmański, Ewa Brocka, Lucjan Pawlicki
Impact of morbid obesity on pulmonary function
Can impedance cardiography be routinely applied in patients with sepsis and severe sepsis?
Introduction: In the European Union only, about 146 000 patients die due to sepsis per year. Impedance cardiography (ICG) is a totally non-invasive and thus devoid of the risk of the above complications method of moni...
BNP in the differential diagnosis of amiodarone-induced pulmonary toxicity: a case report and review of the literature
A 70-year old man with a history of surgically treated lung cancer, ST-elevation myocardial infarction treated with primary angioplasty, congestive heart failure, and on treatment with amiodarone was admitted to the in...
Exercise h-FABP plasma concentration in healthy subjects
Cholinesterase inhibitors for Parkinson’s disease-related visual hallucinations unresponsive to atypical antipsychotics
Introduction: Considering lack of accepted guideline in cases of Parkinson’s disease-related visual hallucinations with poor response or intolerance to antipsychotics, and their possible cholinergic pathogenesis, the tri...